No Data
No Data
Express News | World Health Organization Says Mpox Continues To Constitute A Public Health Emergency Of International Concern
Oppenheimer Maintains Inovio Pharmaceuticals(INO.US) With Buy Rating, Cuts Target Price to $15
The Analyst Landscape: 4 Takes On Inovio Pharmaceuticals
Inovio Pharma Price Target Cut to $5.00/Share From $12.00 by HC Wainwright & Co.
Oppenheimer Maintains Outperform on Inovio Pharmaceuticals, Lowers Price Target to $15
Cautious Hold Recommendation on Inovio Pharmaceuticals Amid Financial Challenges and Competitive Pressures
No Data
No Data